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Oxygen, arterial blood gases and ventilation are 
unchanged during dialysis in patients receiving 
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This study was undertaken to observe whether dialysis-induced alveolar hypoventilation and arterial hypoxaemia 
occur during bicarbonate haemodialysis in patients receiving partial mechanical support with pressure support 
ventilation. Nineteen patients admitted to the medical intensive care unit requiring mechanical ventilation and 
haemodialysis were enrolled. Arterial blood gas, white blood cell (WBC) count, minute ventilation, respiratory rate, 
breathing pattern and blood pressure were measured according to the following time schedule: pre-dialysis (time 0), 
and at 15, 30, 60, 120, 180, 240 min thereafter. Results showed that, with the use of cuprammonium dialyser, the 
WBC count dropped immediately and reached the nadir 1.5 min after haemodialysis. Thereafter, it recovered and 
overshot the pre-dialysis values until the end of dialysis. The bicarbonate dialysate indeed resulted in rapid and 
significant metabolic alkalosis. However, no decrease of PaO, occurred throughout haemodialysis. The tidal 
volume, minute ventilation and breathing pattern remained stable during haemodialysis. We conclude that neither 
dialysis-induced alveolar hypoventilation nor arterial hypoxaemia developed during bicarbonate dialysis in patients 
mechanically ventilated with the pressure support ventilation. 
RESPIR. MED. (1998) 92, 534-540 
Introduction 
Since the report by Johnson et al. (l), the occurrence of 
arterial hypoxaemia during haemodialysis has been well 
confirmed in recent decades. According to the statement in 
the review article of Cardoso et al. (2), most of the falls of 
PaO, ranged from approximately 5% to 15% below the 
pre-dialysis values and most dialysed patients remained 
asymptomatic during the modest hypoxaemia. However, 
this condition may contribute to morbidity during haemo- 
dialysis in patients with compromised cardiopulmonary 
function. 
Haemodialysis-induced alveolar hypoventilation and 
hypoxaemia have been investigated extensively in renal 
failure patients who breathe spontaneously. However, only 
six studies were performed on mechanically ventilated 
critically ill patients, a group in which hypoxaemia is a 
great danger, and the results are conflicting (3-8). In 
addition, the mode of mechanical ventilation used in most 
of these studies was the control mode, with patients sedated 
or paralysed to ensure constant minute ventilation. The 
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changes of oxygenation during haemodialysis of patients 
receiving partial mechanical ventilatory support have not 
been studied before. 
Pressure support ventilation (PSV) is a form of mechan- 
ical ventilatory support that assists an intubated patient’s 
spontaneous breathing with a clinician-selected amount of 
positive airway pressure. This pressure helps to unload the 
ventilatory muscles from the work of breathing associated 
with ventilatory demands and respiratory system imped- 
ances. Except for the inspiratory pressure level set by the 
clinician, patients trigger the ventilator themselves and 
determine tidal volume, respiratory rate, minute ventilation 
and breathing pattern by their own respiratory drive (9). 
PSV has been suggested to improve synchrony between 
patients and the ventilator and proposed to be a useful 
mode in weaning patients from mechanical ventilation (10). 
With the technological advances in resuscitation and life 
support for patients with critical illness, the prevalence of 
patients with both renal and respiratory failure is increasing 
in the intensive care unit (ICU). In those renal failure 
patients who are recovering from acute respiratory failure 
and receive partial ventilatory support with PSV, a decrease 
in arterial oxygenation during haemodialysis may interfere 
with the weaning from mechanical ventilation at this un- 
stable stage. The aim of this prospective study was to 
observe, with routinely used high-concentration bicarbo- 
nate dialysate (35 meq l- ‘), whether bicarbonate dialysis 
would produce a metabolic alkalosis which then would 
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result in hypoventilation and thus a secondary decrease in 
arterial PaO, in patients receiving mechanical ventilation 
with PSV. 
Materials and Methods 
PATIENTS 
Nineteen patients (mean age 71 & 9 years range 56-95 
years; 11 males, eight females) admitted to the medical ICU 
(MICU) of Chang Gung Memorial Hospital requiring 
mechanical ventilation and haemodialysis were enrolled in 
this study. The relevant clinical data are listed in Table 1. 
The causes of renal failure were acute renal failure (n= 12) 
acute exacerbation on chronic renal insufficiency (n=2) or 
chronic renal failure on regular haemodialysis (n=5). The 
duration of haemodialysis at the time of entry into the 
study ranged from 1 week to 13 yr. The pre-dialysis serum 
BUN and creatinine ranged from 46 to 104 mg dl - ’ (mean 
68& 16mgdll’ and from 4.1 to 8.4 mg dl- ’ (mean 
6.1 & 1.4 mg dl - ‘). The pre-dialysis APACHE III score 
(11) ranged from 47 to 117 (mean 77 & 17). Only patients 
with stable blood pressure during previous haemodialysis 
were enrolled in order to eliminate the influence of haemo- 
dynamic unstabilities on arterial oxygenation. The study 
was approved by the institutional committee on human 
research of Chang Gung Memorial Hospital. Informed 
consent was obtained from the closest relatives after a full 
explanation of the nature of the study. 
DIALYSIS AND MECHANICAL VENTILATION 
SETTING 
A cuprammonium rayon membrane dialyser (AM-50 
1.0 m2 Asahi Medical Co Ltd, Tokyo, Japan) was used, and 
the first haemodialysis session of this dialyser was included 
in this study. Blood access was provided by a single-needle 
femoral puncture. Bicarbonate dialysate was used and the 
dialysate was delivered with a single-pass system. The 
bicarbonate dialysate used in our hospital contained a high 
concentration of HCO, - (35 meq I - I). The remaining 
components of the dialysate were sodium (140 meq l- ‘), 
potassium (2.0 meq 1 - ‘), calcium (7 0 meq 1 - ‘), magne- 
sium (1 .O meq I- I), chloride (106 meq 1 - I), acetic acid 
(4.0 meq I- ‘) and glucose (200 mg%). The dialysate and 
blood flow were 500 ml min - ’ and 200 ml min - ‘, respect- 
ively. The duration of each haemodialysis session was 4 h. 
The patients were ventilated with an intensive care ventila- 
tor PB-7200 ae (Puritan Bennett INT’L Inc., Carlsbad, CA, 
U.S.A.) or Servo 900C (Siemens-Elema, Lund, Sweden). 
The ventilatory mode was pressure support mode, and Fro, 
ranged from 25% to 35%. The level of preset pressure 
ranged from 6 to 14 cmH,O above PEEP. The pre-dialysis 
RO, level and ventilatory settings were set by the respirat- 
ory therapist according to the patient’s clinical condition 
and were kept constant throughout haemodialysis. None of 
the patients was sedated or paralysed during haemodialysis. 
MEASUREMENTS 
Measurement of Blood Gas and Leukocyte Count 
Arterial blood gas and white blood cell (WBC) count were 
sampled from a radial artery catheter. The blood was kept 
anaerobically and iced for immediate assay of PaO,, 
PaCO,, pH, SaO, and HCO, - with a blood gas analyser 
(Corning 178, Ciba Corning Diagnostic Corp., MA, 
U.S.A.). Measurement of the WBC count was made with a 
Coulter counter JT-842 (Coulter Electronics, Inc., Hialeah, 
FL, U.S.A.). The alveolar-arterial oxygen gradient, 
~C-4% was calculated according to the following 
equations: P(A-a)O, = PAO, - PaO,; PAO, = (760 - PBH, 
O)AO, - 1.25PaC0,. 
Measurement of Ventilation and Breathing Pattern 
Airway pressure, minute ventilation, breathing pattern and 
flow rate were measured with a Bicore CP-100 pulmonary 
mechanics monitor (Irvine, CA). The flow was measured by 
a flow sensor (VarFlex Flow Transducer, Bicore Monitor- 
ing Systems, Irvine, CA, U.S.A.) positioned between the 
Y-piece and the endotracheal tube based on the principle 
that flow can be calculated by measuring the differential 
pressure generated by an airflow passing through a resistor. 
Tidal volume was obtained by numerical integration from 
the inspiratory flow signal. Airway pressure was measured 
through a catheter attached to the flow sensor. Minute 
ventilation (VE), respiratory rate (RR), and the breathing 
pattern [tidal volume (VT), durations of inspiration (7l) and 
expiration (re), duty cycle (Zl/Te) and shallow breathing 
index (RR/VT) (12)] were electronically analysed and 
calculated from the flow signal. All digital parameters 
derived from the Bicore CP-100 were breath-by-breath 
continuously recorded and stored in a personal computer in 
a spreadsheet form for subsequent retrieval and analysis. 
Measurement of Haemodynamics 
Systolic, diastolic and mean blood pressures (BPS) were 
recorded from an on-line HP Component Monitoring 
System (Hewlett-Packard model 56S, M 1165A Boblingen, 
Germany) through the arterial catheter. An average of the 
five sets of haemodynamic data was taken at the time of 
blood sampling. 
STUDY PROTOCOL 
A VarFlex flow sensor was connected to the endotracheal 
tube and Bicore CP-100 pulmonary monitor at least 30 min 
before initiation of haemodialysis. To avoid spontaneous 
variation in breathing effort, mean values of the breaths 
5 min before blood sampling were used to represent the 
ventilatory status of that period. An arterial line catheter 
was inserted before haemodialysis for blood sampling and 
haemodynamics monitoring. The time schedule for 
measurements was pre-dialysis (time 0) and then at 15, 30, 
60, 120, 180, 240 min thereafter. 
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TABLE 3. Time course changes of ventilation and breathing pattern during haemodialysis 
0 min 15 min 30 min 60 min 120 min 180 min 240 min 
VT (Id) 505 f 42 518Zt43 537 f 43 543 !c 45 521 f 42 525 f 39 509 f 37 
I/E (1 min - ‘) 9.50 xi 0.66 9.95 f 0.75 9.98 f 0.76 9.69 k 0.76 9.47 + 0.73 10.35 f 0.85 10.31 + 0.98 
RR (breaths min - ‘) 21 i 1 21& 1 21 f 1 20&l 20 zt 1 22* 1 22& 1 
TIlTtot (%) 34.1 -f 1.2 34.7 * 1.5 35.2 f 1.4 34.8 f 1.5 34.3 h 1.6 36.2 h 1,7 36.5 zt 1.8 
RR/ VT (breaths 1 min - ‘) 50 f 6 50 k 6 47 f 5 47 zt 8 45 zt 5 49 * 5 47 f 5 
PIFR (1 s - ‘) 0.71 f 0.04 0.70 & 0.04 0.72 & 0.04 0.71 f 0.04 0.69 f 0.04 0.75 f 0.04 0.75 f 0.07 
VT, tidal volume; VE, minute ventilation; RR, respiratory rate; Il/Ttot, duty cycle; RR/VT, shallow breathing index; PIFR, 
peak inspiratory flow rate. 
STATISTICAL ANALYSIS 
The results obtained were expressed as mean f SEM. 
Because of the uneven distribution of the data, Friedman 
two-way ANOVA by ranks was used for repeated measures 
of multiple related samples. Post hoc comparisons between 
pairs of the data of each time interval and the pre-dialysis 
value were performed by Wilcoxon matched-pairs signed- 
ranks test. A probability level less than 0.05 was considered 
significant. 
Results 
The time course changes of arterial blood gas, WBC count 
and haemodynamics are listed in Table 2. The WBC count 
dropped immediately and reached the nadir 15 min after 
the start of haemodialysis. Thereafter, it recovered to the 
pre-dialysis level after about 1 h of dialysis and overshot the 
control value significantly at the end of the second hour. It 
remained high until the end of haemodialysis. However, the 
profound and transitory fall in WBC count did not result in 
aggravation of P(A-a)o, throughout haemodialysis. With 
the use of a high concentration of bicarbonate dialysate 
(35 meq 1 - ‘), the serum bicarbonate level increased rapidly 
and reached a significant level early by the end of the first 
15 min of haemodialysis. It remained high thereafter. Our 
patients also became significantly alkalotic 60 min after the 
commencement of dialysis (pH from 7.404 f 0.019 to 
7.426 + 0.018). The pH level elevated gradually until the 
end of haemodialysis. The haemodynamics of our patients 
remained stationary during haemodialysis. 
The changes of minute ventilation and breathing patterns 
are listed in Table 3. In spite of rapid alkalization of body 
fluid by bicarbonate dialysate, there were no decrease in VT 
and RR and thereby in VE throughout haemodialysis 
(Table 3). TUTtot, RR/VT and PIFR also varied negligibly 
between each time interval and pre-dialysis values. No 
significant decrease of PaO, occurred during haemodialysis 
(Table 2). There was a slight increase in PaCO,, but this did 
not reach a significant level. Therefore, haemodialysis 
neither resulted in alveolar hypoventilation or arterial 
hypoxaemia nor altered the breathing pattern in patients 
receiving mechanical ventilation with PSV, despite rapid 
serum alkalization induced by the bicarbonate dialysate. 
Discussion 
The main results of our study were (1) a transitory fall of 
WBC count with stationary P(A-a)O, level, (2) rapid and 
significant serum metabolic alkalosis in the bicarbonate 
dialysis and (3) stable breathing pattern with no alveolar 
hypoventilation and arterial hypoxaemia during dialysis 
under the partial ventilatory support with PSV. 
Two main factors are implicated in the genesis of 
dialysis-induced hypoxaemia: (1) impaired gas exchange 
caused by intrapulmonary leukostasis and ventilation- 
perfusion mismatch for the sake of complement activation 
from poorly biocompatible dialyser membrane and (2) 
alveolar hypoventilation of multiple origins from different 
dialysate (2). Like many previous reports proposed for 
bioincompatible dialyser membranes (13-20), the cupram- 
monium dialyser resulted in a temporary fall in WBC count 
early during haemodialysis. The pattern of WBC changes 
parallelled the results of De Baker et al. (14) and others 
(19,21-23) in that it reached the nadir 15 min after the start 
of haemodialysis and recovered to the pre-dialysis level by 
the end of the first hour after dialysis began and overshot 
the baseline values 2 h following the onset of dialysis. 
However, the transitory leukopenia did not exacerbate the 
pulmonary gas exchange ability and P(A-a)O, and PaO, 
remained stationary throughout haemodialysis. 
Contrasting mechanisms have been proposed to explain 
alveolar hypoventilation with acetate or bicarbonate 
dialysis. With acetate dialysate, the main mechanism is 
decreased gaseous CO, production during acetate metab- 
olism (24,25). With bicarbonate dialysate, the mechanism 
responsible appears to be a suppression of respiratory drive 
by rapid alkalization of body fluids resulting from a gain of 
bicarbonate from the dialysate (26,27). 
Although bicarbonate, rather than acetate, dialysate has 
been suggested to have a protective effect in the occurrence 
of dialysis-induced hypoxaemia (13-l 7), hypoxaemia dur- 
ing bicarbonate dialysis was observed by some authors 
(18,26,28,29). Several reports have confirmed the arterial 
hypoxaemia during bicarbonate dialysis and argued that 
low-concentration bicarbonate dialysate (29 meq 1 - ‘) 
could prevent dialysis-induced hypoxaemia, but PaO, 
would decrease when a bicarbonate dialysate of higher 
concentration was utilized (28,30,31). With the same 
cuprammonium dialyser membrane used in our study, 
Ganss et al. (31) demonstrated a significant reduction in 
arterial PaO, during dialysis with both acetate and high- 
concentration bicarbonate dialysate (36.4 & 2.18 meq 1~ ‘), 
but no significant changes with low-concentration bicarbo- 
nate dialysate (29 meq l- ‘) were noted. The dialysate 
utilized in our study contained a high concentration of 
HCO, - (35 meq 1~ ‘), and this is the concentration rou- 
tinely used in our institution for bicarbonate dialysis. The 
mechanical ventilatory support with PSV is the only differ- 
ence in the study design as compared with the report of 
Ganss et al. Our patients indeed became significantly alka- 
lotic soon after dialysis began (Table 2). Although the pH 
rose significantly at the end of the first hour in both studies, 
our results were different from those of Ganss et al. and 
showed no decline of PaO, during haemodialysis. 
Relative to the numerous surveys performed on renal 
failure patients who breathe spontaneously, investigations 
on the mechanically ventilated ICU patients are rare. 
Several authors have shown that fixed ventilation by 
control mode mechanical ventilation got rid of alveolar 
hypoventilation and dialysis-induced hypoxaemia no mat- 
ter which dialysate was used (558). Contrary to the control 
mode applied in those papers, PSV is a mode of spon- 
taneous breathing with partial mechanical support. With 
PSV, the clinician only selects the preset pressure level, 
while the patients trigger the ventilator and control the tidal 
volume, respiratory rate and inspiratory flow themselves. 
According to the mechanism of dialysis-induced hypoxae- 
mia for bicarbonate dialysate proposed before, the rapid 
and significant metabolic alkalosis should suppress the 
respiratory drive and result in hypoventilation. However, 
not only did the tidal volume, respiratory rate and minute 
ventilation remain stationary, the breathing pattern also 
varied negligibly with no significant changes in TilTtot, 
RR/ VT or PIFR during haemodialysis (Table 3) even under 
the mechanical ventilatory support with PSV. Therefore, 
haemodialysis did not result in alveolar hypoventilation 
and did not alter the breathing pattern despite rapid serum 
alkalization induced by the bicarbonate dialysate. 
In conclusion, in patients with combined renal and 
respiratory failure, being mechanically ventilated with PSV, 
haemodialysis with a high-concentration bicarbonate 
dialysate did not lead to alveolar hypoventilation and 
hypoxaemia. 
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